The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 13, 2015
Filed:
Jul. 15, 2013
Applicants:
Gilead Sciences, Inc., Foster City, CA (US);
Selcia Limited, Essex, GB;
Inventors:
Todd Appleby, San Francisco, CA (US);
Hans G. Fliri, Essex, GB;
Andrew J. Keats, Essex, GB;
Linos Lazarides, London, GB;
Richard L. Mackman, Millbrae, CA (US);
Simon N. Pettit, Essex, GB;
Karine G. Poullennec, Essex, GB;
Jonathan Sanvoisin, Essex, GB;
Victoria A. Steadman, Essex, GB;
Gregory M. Watt, Bristol, GB;
Assignees:
Gilead Sciences, Inc., Foster City, CA (US);
Selcia Limited, Ongar, Essex, GB;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07D 498/18 (2006.01); A61K 38/06 (2006.01); A61K 45/06 (2006.01); C07D 498/08 (2006.01); C07K 5/062 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
A61K 38/06 (2013.01); C07D 498/18 (2013.01); A61K 45/06 (2013.01); C07D 498/08 (2013.01); C07K 5/06052 (2013.01); C07K 58/02 (2013.01); C07D 487/08 (2013.01);
Abstract
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.